Mankind Pharma Ltd.(IN:MANKIND)
₹2,639.90+34.55 (+1.33%)
IN:MANKIND
Mankind Pharma Ltd. financials statements
₹2,639.90
At close:+34.55 (+1.33%)
Want to see IN:MANKIND full AI Analyst Report?
Mankind Pharma Ltd. (MANKIND) Income Statement
15 Followers
Mankind Pharma Ltd. Income Statement
Last quarter (Q2 2027), Mankind Pharma Ltd.'s total revenue was ₹43.38B, an increase of 17.33% from the same quarter last year. In Q2, Mankind Pharma Ltd.'s net income was ₹7.11B. See Mankind Pharma Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| ₹ 142.78B | ₹ 122.07B | ₹ 102.59B | ₹ 87.49B | ₹ 77.82B | |
| ₹ 61.55B | ₹ 86.38B | ₹ 70.02B | ₹ 57.87B | ₹ 53.12B | |
| ₹ 34.24B | ₹ 61.22B | ₹ 47.63B | ₹ 41.45B | ₹ 34.28B | |
| Depreciation and Amortization | ₹ 8.86B | ₹ 6.21B | ₹ 3.98B | ₹ 3.26B | ₹ 1.67B |
| ₹ 38.58B | ₹ 35.58B | ₹ 28.24B | ₹ 20.37B | ₹ 21.97B | |
| ₹ 27.31B | ₹ 25.16B | ₹ 22.39B | ₹ 16.42B | ₹ 18.84B | |
| ₹ -3.99B | ₹ 5.00M | ₹ 1.59B | ₹ 296.23M | ₹ 909.65M | |
| ₹ 23.33B | ₹ 25.16B | ₹ 23.98B | ₹ 16.71B | ₹ 19.75B | |
| ₹ 19.13B | ₹ 19.91B | ₹ 19.13B | ₹ 12.82B | ₹ 14.33B | |
| Per Share Metrics | |||||
| Basic EPS | ₹ 46.35 | ₹ 49.17 | ₹ 47.75 | ₹ 32.00 | ₹ 35.78 |
| Diluted EPS | ₹ 46.28 | ₹ 49.09 | ₹ 47.68 | ₹ 32.00 | ₹ 35.78 |
| Weighted Average Shares Outstanding | 412.71M | 404.67M | 400.59M | 400.59M | 400.59M |
| Weighted Average Shares Outstanding (Diluted) | 413.34M | 404.67M | 401.17M | 400.59M | 400.59M |
Currency in INR

